Leerink Partnrs Issues Optimistic Forecast for INSP Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Investment analysts at Leerink Partnrs boosted their Q4 2024 earnings estimates for shares of Inspire Medical Systems in a research report issued to clients and investors on Monday, November 4th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings of $0.77 per share for the quarter, up from their prior estimate of $0.72. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $0.75 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ Q4 2025 earnings at $1.12 EPS and FY2028 earnings at $5.77 EPS.

INSP has been the subject of several other reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a research report on Tuesday. Stifel Nicolaus restated a “hold” rating and issued a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday. Morgan Stanley reduced their target price on shares of Inspire Medical Systems from $250.00 to $210.00 and set an “overweight” rating on the stock in a report on Monday, July 15th. Leerink Partners boosted their price target on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the stock a “market perform” rating in a research note on Tuesday, September 10th. Finally, Wells Fargo & Company upped their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems presently has a consensus rating of “Moderate Buy” and an average target price of $227.75.

Inspire Medical Systems Trading Down 5.3 %

INSP stock opened at $200.47 on Wednesday. The business’s fifty day moving average price is $201.94 and its 200 day moving average price is $179.94. Inspire Medical Systems has a 12-month low of $123.00 and a 12-month high of $257.40. The company has a market capitalization of $5.98 billion, a PE ratio of 187.43 and a beta of 1.36.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.51% and a net margin of 4.37%. The company had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter in the previous year, the company earned ($0.29) earnings per share. The firm’s quarterly revenue was up 32.6% compared to the same quarter last year.

Insider Buying and Selling

In other news, insider Randy Ban sold 4,861 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total transaction of $916,541.55. Following the completion of the transaction, the insider now directly owns 3,056 shares of the company’s stock, valued at approximately $576,208.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Shawn Mccormick sold 800 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the transaction, the director now owns 23,140 shares in the company, valued at approximately $5,090,800. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Randy Ban sold 4,861 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $188.55, for a total transaction of $916,541.55. Following the completion of the transaction, the insider now directly owns 3,056 shares in the company, valued at $576,208.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,692 shares of company stock worth $1,099,207. Corporate insiders own 4.10% of the company’s stock.

Institutional Investors Weigh In On Inspire Medical Systems

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of New York Mellon Corp grew its holdings in shares of Inspire Medical Systems by 32.3% during the second quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock worth $105,433,000 after purchasing an additional 192,238 shares during the last quarter. William Blair Investment Management LLC grew its stake in Inspire Medical Systems by 1.8% during the 2nd quarter. William Blair Investment Management LLC now owns 770,413 shares of the company’s stock worth $103,104,000 after buying an additional 13,602 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Inspire Medical Systems by 51.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 459,766 shares of the company’s stock worth $98,754,000 after buying an additional 156,893 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in Inspire Medical Systems by 798.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock valued at $56,530,000 after buying an additional 238,034 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in Inspire Medical Systems by 152.7% in the second quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock valued at $31,028,000 after buying an additional 140,090 shares during the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.